Volume 1 Issue 3
Dec.  2022
Turn off MathJax
Article Contents
Article Navigation >  Clinical Cancer Bulletin  > 2022  >  1(3): 164-166
Yongbing QIAN. Comprehensive Prevention of COVID-19 Infection in Immunocompromised Individuals with Cancer or Solid Organ Transplant[J]. Clinical Cancer Bulletin, 2022, 1(3): 164-166. doi: 10.11910/j.issn.2791-3937.2022.20220022
Citation: Yongbing QIAN. Comprehensive Prevention of COVID-19 Infection in Immunocompromised Individuals with Cancer or Solid Organ Transplant[J]. Clinical Cancer Bulletin, 2022, 1(3): 164-166. doi: 10.11910/j.issn.2791-3937.2022.20220022
shu

Comprehensive Prevention of COVID-19 Infection in Immunocompromised Individuals with Cancer or Solid Organ Transplant

doi: 10.11910/j.issn.2791-3937.2022.20220022
  • 1.

    Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

  • 2.

    Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai 200127, China

  • 3.

    Shanghai Institute of Transplantation, Shanghai 200127, China

More Information
  • Corresponding author: qianyb79@hotmail.com
  • Received Date: 05 Dec 2022
  • Accepted Date: 09 Mar 2023
    • Available Online: 10 Mar 2023
  • Publish Date: 25 Dec 2022
    Abstract
    • FullText(HTML)
  • loading
    • References(10)
  • [1]
    Song Q, et al. Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative. J Clin Oncol. 2022 May 1;40(13): 1414-1427.
    [2]
    Trapani S, et al. Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study. Am J Transplant. 2021 Jul;21(7): 2509-2521.
    [3]
    Guangyu Ao, et al. The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis. Transplant Rev (Orlando). 2021 Jul;35(3): 100628.
    [4]
    Clarke JA, et al. Excess Mortality Among Solid Organ Transplant Recipients in the United States During the COVID-19 Pandemic. Transplantation. 2022 Dec 1;106(12): 2399-2407.
    [5]
    Cho K, et al. Immunogenicity of COVID-19 vaccines in patients with diverse health conditions: A comprehensive systematic review. J Med Virol. 2022 Sep;94(9): 4144-4155.
    [6]
    Simon Galmiche, et al. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect. 2022 Feb;28(2): 163-177.
    [7]
    Myron J Levin, et al. Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19. N Engl J Med. 2022 Jun 9;386(23): 2188-2200.
    [8]
    Al Jurdi A, et al. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave. Am J Transplant. 2022 Dec;22(12): 3130-3136.
    [9]
    Bertrand D, et al. Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients. Kidney Int. 2022 Aug;102(2): 440-442.
    [10]
    Kertes J, et al. Association Between AZD7442 (Tixagevimab-Cilgavimab) Administration and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Hospitalization, and Mortality. Clin Infect Dis. 2023 Feb 8;76(3): e126-e132.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article Views(84) PDF Downloads(11) Cited by()
    Proportional views
    Related

    Contacts

    Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return